Each daily consumption of 12 g alcohol increases risk for cirrhosis by 6.2 percent, hepatocellular carcinoma by 11.5 percent
WEDNESDAY, Jan. 29, 2025 (HealthDay News) — For patients with hepatitis B virus, alcohol is associated with dose-dependent increased risks for cirrhosis and hepatocellular carcinoma (HCC), according to a review published online Jan. 21 in the Journal of Clinical and Translational Hepatology.
Yin-Ping Wu, from the Qilu University Hospital of Shandong University in Jinan, China, and colleagues pooled data on the incidence of cirrhosis and HCC and developed a dose-dependent model of the effect of alcohol on cirrhosis and HCC. Data were included for 33,272 patients with hepatitis B virus from 45 studies.
The researchers found that the overall pooled odds ratios were 2.27 and 2.61 for cirrhosis and HCC, respectively, among drinkers versus nondrinkers. Compared with low-level drinkers, high-level drinkers had estimated pooled odds ratios of 2.34 and 2.42 for cirrhosis and HCC, respectively. A linear dose-dependent analysis showed that each daily consumption of 12 g of alcohol increased the risks for cirrhosis and HCC by 6.2 and 11.5 percent, respectively.
“Our meta-analysis is the first report to show that alcohol consumption increases the risk of cirrhosis and HCC in patients with HBV infection in a dose-dependent manner,” the authors write.
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Alcohol-Attributable Cancer Mortality Has Increased Significantly in the U.S. 
Increase Seen in Rates of Xenobiotic-Induced Liver Injury From 2020 to 2024 
Link Between Liver Fibrosis in MASLD, ASCVD Varies by Glycemic Status 
Higher Coffee Consumption Linked to Favorable Indicators of Liver Health 
Stepped Alcohol Treatment Via Telehealth Reduces Alcohol Use 
New Model Performs Well for Detecting Alcohol-Associated Liver Disease 
